SCHEMBL24568619

SCHEMBL24568619

Cc1cccnc1-c1cncs1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.51
METAP2 P50579 1/20 0.44
DYRK1A Q13627 2/20 0.41
TBXAS1 P24557 1/20 0.41
DYRK2 Q92630 1/20 0.41
DYRK1B Q9Y463 1/20 0.41
CNR2 P34972 1/20 0.40
PIM1 P11309 2/20 0.39
KDM4E B2RXH2 1/20 0.39
TSHR P16473 1/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
CD38 P28907 1/20 0.39
NOS3 P29474 1/20 0.38
NOS1 P29475 1/20 0.38
NOS2 P35228 1/20 0.38
LRRK2 Q5S007 1/20 0.38
TRPV1 Q8NER1 2/20 0.35
NPC1 O15118 1/20 0.34
HSP90AA1 P07900 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28019355 0.82 CYP2A6 (0.41) CYP2A6METAP2DYRK1ATBXAS1DYRK2
SCHEMBL27164862 0.79 PIM1 (0.45) DYRK1ATBXAS1DYRK2DYRK1BPIM1
SCHEMBL30482452 0.79 PIM1 (0.45) DYRK1ATBXAS1DYRK2DYRK1BPIM1
SCHEMBL24567811 0.78 TBXAS1 (0.41) CYP2A6DYRK1ATBXAS1DYRK2DYRK1B
SCHEMBL28019354 0.76 DYRK1A (0.40) CYP2A6DYRK1ADYRK2DYRK1BPIM1
SCHEMBL5088040 0.73 KDM4E (0.61) DYRK1ATBXAS1DYRK2DYRK1BPIM1
SCHEMBL29924154 0.73 CYP2A6 (0.61) CYP2A6METAP2CNR2KDM4ETSHR
SCHEMBL196235 0.73 CYP2A6 (0.61) CYP2A6METAP2CNR2KDM4ETSHR
SCHEMBL31252534 0.73 CYP2A6 (0.61) CYP2A6METAP2CNR2KDM4ETSHR
SCHEMBL28416665 0.73 PIM1 (0.41) CYP2A6DYRK1ADYRK2DYRK1BPIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022140428-A2 INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. (US) 2022-06-30 WO disclosed